Centessa Pharmaceuticals plc (CNTA)
NASDAQ: CNTA · Real-Time Price · USD
14.07
+0.33 (2.40%)
At close: Jul 3, 2025, 1:00 PM
14.39
+0.32 (2.27%)
After-hours: Jul 3, 2025, 2:04 PM EDT

Centessa Pharmaceuticals Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019
Period Ending
Mar '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019
15-6.85---
Upgrade
Gross Profit
15-6.85---
Upgrade
Selling, General & Admin
49.7150.8153.7355.243.011.14
Upgrade
Research & Development
161.04150.24124.41155.0896.329.3
Upgrade
Operating Expenses
210.74201.06178.14210.28139.3310.44
Upgrade
Operating Income
-195.74-201.06-171.28-210.28-139.33-10.44
Upgrade
Interest Expense
-10.44-10.09-9.91-7.28-2.55-0.38
Upgrade
Interest & Investment Income
19.3214.0210.480.24--
Upgrade
Currency Exchange Gain (Loss)
-0.36-1.80.8-2.8-3.6-
Upgrade
Other Non Operating Income (Expenses)
0.140.11-0.33-0.76-0.770.16
Upgrade
EBT Excluding Unusual Items
-187.09-198.82-170.24-220.87-146.25-10.66
Upgrade
Other Unusual Items
-33-34.1-5.93.92-15.08-
Upgrade
Pretax Income
-220.09-232.91-176.14-216.95-381.79-10.66
Upgrade
Income Tax Expense
3.762.84-25.06-0.750.11-
Upgrade
Net Income
-223.85-235.76-151.09-216.21-381.9-10.66
Upgrade
Preferred Dividends & Other Adjustments
-----0.83-
Upgrade
Net Income to Common
-223.85-235.76-151.09-216.21-381.07-10.66
Upgrade
Shares Outstanding (Basic)
12311496937515
Upgrade
Shares Outstanding (Diluted)
12311496937515
Upgrade
Shares Change (YoY)
26.02%19.02%2.97%24.26%401.11%-
Upgrade
EPS (Basic)
-1.82-2.06-1.57-2.31-5.07-0.71
Upgrade
EPS (Diluted)
-1.82-2.06-1.57-2.31-5.07-0.71
Upgrade
Free Cash Flow
-162.05-142.09-160.51-201.68-136.34-10.63
Upgrade
Free Cash Flow Per Share
-1.32-1.24-1.67-2.16-1.81-0.71
Upgrade
Gross Margin
100.00%-100.00%---
Upgrade
Operating Margin
-1304.95%--2499.39%---
Upgrade
Profit Margin
-1492.31%--2204.66%---
Upgrade
Free Cash Flow Margin
-1080.33%--2342.20%---
Upgrade
EBITDA
-195.42-200.71-170.97-210.15-139.3-10.43
Upgrade
D&A For EBITDA
0.320.340.310.130.030.01
Upgrade
EBIT
-195.74-201.06-171.28-210.28-139.33-10.44
Upgrade
Updated May 14, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q